China’s medical PVC pellet production exceeds 200,000 tons, high-end is the future trend

Medical PVC pellets have chemical corrosion resistance and super resistance to oxidants, reducing agents, and strong acids. They are also wear-resistant, easy to produce, safe to use, and low-cost. They are widely used in the production of surgical gloves, surgical coverings, and anesthesia. Supplies, diagnostic and treatment supplies, intravascular cannulas, puncture cannulas, blood circuits and connectors, cardiac circuits and connectors, oxygenators and accessories, thoracic and abdominal catheters and other products.

Based on the different phthalate content, medical PVC pellets can be divided into: phthalate-based medical PVC pellets (such as DOP as the plasticizer) and phthalate-free medical PVC pellets (such as mainly DEHT). According to different material properties, medical PVC pellets can be divided into light-proof PVC pellets, PVC selective light-transmitting materials, PVC developing materials, PVC frosted materials, PVC high Vicat pellets, etc.

There are hundreds of PVC pellet manufacturers in China, but there are only a few medical PVC pellet manufacturers, and the scale of medical PVC pellet companies is generally not high. The scale of most companies is less than 10,000 tons/year. At present, China’s medical PVC granule manufacturers are mainly concentrated in East China and North China. The main manufacturers include Shenzhen Hengfangda Polymer Materials Technology Co., Ltd., Suzhou Mingchang Plastic Co., Ltd., Shanghai Xinshanghua Polymer Materials Co., Ltd., Shanghai Chlor-Alkali Chemical Co., Ltd., etc. Among them, Shenzhen Hengfangda Polymer Materials Technology Co., Ltd. is the largest medical PVC pellet manufacturer in China, with a current production capacity of more than 70,000 tons per year.

As the aging population continues to worsen, the number of patients with cardiovascular diseases and other diseases is also increasing, providing a foundation for the growth of market demand for medical PVC pellets. According to the “2022-2026 Medical PVC Granules Industry In-Depth Market Research and Investment Strategy Suggestions Report“, China’s medical PVC in 2021 The output of pellets exceeds 200,000 tons.

Industry analysts said that with people’s awareness of the dangers of phthalates as plasticizers in medical PVC materials With the deepening of market share, the market share of non-phthalic medical PVC pellets will continue to increase. At the same time, fillers such as stabilizers, lubricants, and plasticizers need to be added during the reproduction process of medical PVC pellets. These fillers play a decisive role in the performance of PVC products. Manufacturing companies can increase R&D investment in this field.

In addition, my country’s medical PVC pellet industry faces industrial structural contradictions. There is sufficient supply in the field of low-end products, but there is a lack of high-end products. In the future, with the continuous improvement of medical and health conditions and the improvement of residents’ living standards, the demand for high-end medical PVC pellets will continue to grow. Domestic manufacturers should strengthen the development of high-end products to increase the added value of products.